Estomil

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Estomil

Property Description
Active ingredient Lansoprazole
Form Delayed-Release Capsules, Orally Disintegrating Tablets
Pharmacological class Proton Pump Inhibitor (PPI)
General purpose Sustained reduction of gastric acid secretion
Origin Synthetic compound (substituted benzimidazole)

Estomil is a prescription medicine defined by its active component, Lansoprazole. It belongs to the pharmacological class of Proton Pump Inhibitors (PPIs), a highly specific type of antisecretory compound. Its fundamental purpose is to achieve the profound and sustained suppression of acid production in the stomach, thereby mitigating symptoms associated with excessive gastric acidity.

What Type of Medicine is Estomil?

Estomil is a globally recognized brand containing the active ingredient Lansoprazole, which is structurally defined as a substituted benzimidazole and functions as a prodrug. The medication is clinically recognized for its high potency in acid suppression. This pharmacological action means the drug provides a way to control the high-acid environment of the stomach, representing a synthetic, single-component approach to gastric management.

Composition and Purpose: The Role of Delayed Release

The formulation of Estomil is engineered for oral administration, typically as a Delayed-Release Capsule or a Distinctive Orally Disintegrating Tablet. This composition is essential because it utilizes enteric-coated granules or micro-pellets to shield the acid-sensitive Lansoprazole from deactivation by stomach acid before absorption. This protective delivery system ensures the active substance successfully reaches the parietal cells for the targeted blockade of acid production. The resulting sustained reduction of secretion provides the primary therapeutic benefit, which helps alleviate discomfort and promotes an optimal environment for the natural healing of acid-related irritations.

What side effects are possible with Estomil?

Possible Side Effects and Safety Information

The safety profile of Estomil (Lansoprazole), as officially documented by regulatory authorities, details adverse reactions classified by frequency and affected organ system. Reactions categorized as Common (may affect up to 1 in 10 people) primarily involve the gastrointestinal and nervous systems, including headache, diarrhea, abdominal pain, nausea, and constipation.


Frequency and System-Organ Class

Adverse reactions classified as Uncommon include dizziness, fatigue, skin rash, pruritus, and changes in liver enzyme levels. Rare documented effects may involve hematologic changes such as thrombocytopenia and serious renal reactions like Acute Tubulointerstitial Nephritis (TIN).


Documented Serious Safety Concerns

Regulatory labeling highlights several serious adverse reactions. These include the rare occurrence of Severe Cutaneous Reactions (SCARs), such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). Hypomagnesemia (low blood magnesium levels) has been reported with prolonged therapy, often exceeding one year, which may manifest as tetany or arrhythmias.


Long-Term Use and Safety Patterns

Specific safety patterns are linked to duration of use. Therapy lasting over one year is associated with a modest increase in the risk of osteoporosis-related fractures (hip, wrist, spine), particularly in older adults, and potential Vitamin B12 deficiency. The drug is contraindicated for concurrent use with certain antiretroviral medications, such as atazanavir and rilpivirine.

Overdose and Emergency Response

The official information regarding acute overdose with Estomil (Lansoprazole) is strictly defined by mandated emergency procedures and supportive care, as documented by regulatory agencies. Acute experience with high-dose ingestion is limited, and official labeling does not specify a distinct or characteristic set of overdose symptoms, noting only that manifestations may present as an exaggeration of known effects.

In the event of a suspected or confirmed overdose, the regulatory mandate is to seek immediate medical attention or contact a Poison Control Center right away. This urgent action is required for any overdose ingestion.

Management procedures are officially defined as symptomatic and supportive treatment. Official documentation confirms that there is no specific antidote known for Lansoprazole. Furthermore, the active compound cannot be removed from circulation by haemodialysis, a constraint noted in the prescribing information. Supportive steps described in regulatory documents may include measures such as gastric emptying and the use of activated charcoal. Specific overdose severity considerations for pediatric or impaired populations are not explicitly detailed in the official overdose sections.

Therapeutic Uses of Estomil

What Estomil Treats: Main Uses and Benefits

The primary role of Estomil (referring to its pharmacological category) may be part of symptomatic management, commonly used to help with symptoms related to heightened physiological activity. It is applied across therapeutic domains where additional symptomatic support is needed. Estomil is relevant for easing symptoms that become more noticeable. In this pharmacological category, the medication is commonly used to help manage symptoms associated with specific conditions.


Therapeutic Areas of Use

Estomil is considered relevant in contexts marked by increased discomfort or tension, often used during phases when supportive symptom management is appropriate. The medication is applicable in conditions marked by increased physiological stress, where symptoms create noticeable functional strain. It is used in areas where short-term symptom management is appropriate. Indications include its use in situations involving recurrent or episodic manifestations, as well as in acute therapeutic contexts. This offers symptomatic relief that helps patients cope more steadily with symptom fluctuations.

“The primary goal is to help patients manage difficult episodes by reducing the overall symptom load.”


Supportive Benefit Summary

Supportive Relief Focus: Episodic Discomfort
Estomil supports general well-being during symptomatic phases and contributes to easing the overall symptom load in situations where symptoms are associated with acute or episodic changes.

Eligibility and Restrictions for Use

Who can and cannot use Estomil?

Eligibility for Estomil (Lansoprazole) is defined by official government prescribing information, establishing rules based on age, physiological status, and underlying conditions.


Absolute Contraindications (Must Not Use)

Classification Who is Prohibited from Use
Hypersensitivity Patients with a known allergy or severe reaction to Lansoprazole or any component.
Drug-Specific Patients concurrently receiving specific HIV protease inhibitors, such as rilpivirine-containing products.
Metabolic Patients with rare hereditary problems like fructose intolerance due to excipients in the formulation.

Eligibility Based on Age and Condition

Adults are eligible for all approved uses. For pediatric patients, use is established for children and adolescents mathbf1 to mathbf17 years of age for short-term treatment of specific conditions. Use is not recommended in children under mathbf1 year, as safety and efficacy have not been established.

Eligibility is conditional for patients with moderate or severe hepatic (liver) impairment. These patients require caution and should be managed with a lower daily dose. For pregnancy and lactation, use is generally not recommended or avoided as a precautionary measure due to limited clinical data. Patients with renal impairment maintain full eligibility, as no dose adjustment is required.

What should I know about interactions with other medicines?

Estomil Interactions with other medicines and products

Estomil (Lansoprazole) can affect or be affected by other medicines, products, and supplements. These officially documented interactions are primarily due to Lansoprazole's action of reducing gastric acid or its involvement in liver enzyme pathways (CYP enzymes) and transporter systems.


Restrictions and Contraindications

Co-administration with certain HIV protease inhibitors, such as Atazanavir and Rilpivirine, is typically contraindicated or not recommended by regulatory authorities due to the risk of severely reduced exposure of the antiviral drug. Similarly, the absorption of antifungals like Ketoconazole and Itraconazole is decreased, potentially leading to sub-therapeutic concentrations.


Exposure-Altering Interactions

Estomil's plasma concentration is significantly increased when co-administered with the CYP2C19 inhibitor Fluvoxamine. Conversely, the herbal product St John's Wort markedly reduces Estomil levels. Due to the potential for altered plasma concentrations, monitoring is required for patients taking Tacrolimus, Warfarin, or Digoxin.


Timing and Population Cautions

Official labeling requires Sucralfate and Antacids to be administered one hour after Estomil to prevent a reduction in Estomil's absorption. Caution is also advised for patients with hepatic impairment, as the removal of Lansoprazole from the body may be slower, increasing potential interaction effects.

Mechanism of Action

Targeting the Final Step of Acid Production: The Proton Pump Blockade

Estomil acts by engaging the H^+/ K^+- ATPase enzyme, or Proton Pump, which represents the terminal molecular machinery for secreting hydrochloric acid ( HCl) into the stomach. The mechanism is selective and irreversibly inhibits the pump, thereby blocking acid output regardless of upstream triggers like histamine or gastrin.


The Chemical Cascade: pH-Dependent Activation

The active ingredient is an acid-activated prodrug, meaning it remains pharmacologically inert until it is concentrated in the extremely low pH environment of the parietal cell's secretory canaliculi. This pH-dependent activation is necessary as it ensures the drug is only converted into its active, enzyme-binding form (sulfenamide) at the specific site of action, which enables selective action on the Proton Pump.


Sustained Suppression and Biological Turnover

The formation of a covalent bond between the active drug and the pump causes its sustained, non-competitive functional suppression. The physiological recovery of acid-secreting capacity is therefore dependent on the parietal cell's ability to synthesize and incorporate new H^+/ K^+- ATPase molecules to replace the blocked enzymes. This process leads to the sustained suppression of H^+ ion concentration within the stomach lumen.

Dosage and Administration Information

Official Administration Guidelines for Estomil

Estomil, a proton pump inhibitor (PPI), is administered orally and must be taken according to the specific schedule outlined by the prescribing physician. It is typically formulated as a delayed-release orodispersible tablet, which is designed to protect the active medicine from stomach acid until it reaches the intestine for absorption.


Administration Details

Administration Scope Official Instruction
Route of Administration Oral (by mouth).
Timing in relation to meals Must be taken at least 30 minutes before a meal, preferably before breakfast, to maximize efficacy.
Frequency Pattern Typically once daily; for some severe conditions, it may be prescribed twice daily (morning and evening).
Age-Group Rules Generally restricted to adults for most indications. Specific PPIs may be approved for pediatric patients 5 years and older for limited conditions.

Procedural Steps

The orodispersible tablet can be taken in a few specific ways, ensuring the protective coating on the microgranules is not damaged:

  1. Standard Oral Use: Place the tablet on the tongue. Allow it to dissolve in the mouth, then swallow the released microgranules with saliva. Do not chew or crush the microgranules. The tablet may also be swallowed whole with a glass of water.
  2. For Swallowing Difficulties: The tablet may be dispersed in a syringe using a specific volume of water (e.g., 4 mL for a 15 mg dose) and administered orally or via a nasogastric tube. The mixture must be gently shaken until the tablet is dispersed and then administered immediately.

Missed Dose Rule: If a once-daily dose is missed, take it as soon as it is remembered unless it is nearly time for the next scheduled dose. Do not take two doses at the same time to compensate for a missed dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Primary Mechanism of Action

Research has explored whether the agent’s mechanism of action involves selectively activating receptor type R1, which is involved in nerve signal transmission. The primary focus of research has been to examine the study endpoints related to pain associated with condition X.

Studies have investigated this mechanism and whether it was related to measured changes in participant reporting.

Efficacy and Symptom Relief

In studies, researchers evaluated whether there was a difference in the baseline symptom severity measurement over a 12-week period.

  • Symptom Severity: A large-scale randomized controlled trial (RCT) compared the treatment to placebo and to standard-of-care therapies. The study endpoints were measurements using the standardized X-pain scale.
  • Time to Potential Effect: One finding was the time to the first recorded change in measurement, which was observed within the first 48 hours of treatment initiation in some participants.

Safety and Tolerability Profile

Tolerability was monitored using data collected over the studies’ duration. Monitoring of liver enzymes was a required component of the study design.

  • Specific Populations: The study inclusion criteria generally excluded participants with existing severe kidney conditions. Study data are limited regarding administration to pediatric populations.

Combination Therapy Potential

Specific studies investigated administration of the agent in combination with drug Y. Researchers evaluated whether this combination was related to measured study endpoints.

  • Dose Response: In these combination studies, researchers also evaluated whether a difference in dose levels was associated with a corresponding difference in measured outcomes.

Research is ongoing to determine the agent’s relationship to various treatment approaches.

Frequently Asked Questions (FAQ)

Common questions about Estomil (FAQ)

Q: Is Estomil considered a new type of drug?

Estomil contains the active ingredient Lansoprazole, which is part of the class of medicines known as Proton Pump Inhibitors (PPIs). While PPIs are a well-established group, Lansoprazole was first patented in the 1980s and was introduced for medical use in the early 1990s. This places it within the timeline of other internationally approved PPIs.

Q: Is there a generic version of Estomil available?

According to official drug information, the active ingredient in Estomil is Lansoprazole, which is widely available in a generic version. A generic medication has the same active ingredients, strength, dosage form, and route of administration as its brand-name counterpart.

Q: Are there any common foods or drinks that should be avoided when taking Estomil?

Official administration guidelines indicate that Estomil is typically administered at least 30 minutes before a meal. Taking the medicine this way is important because food can potentially decrease the absorption and overall effectiveness of the drug. However, regulatory documents do not list specific foods that must be strictly avoided apart from the timing around meals.

Q: Does Estomil affect birth control pills?

Official regulatory labeling does not state a direct chemical interaction between Lansoprazole and all oral contraceptive medications. However, patient safety information notes that severe side effects like diarrhea or vomiting may potentially reduce the effectiveness of birth control pills.

Q: What are the most common reasons a doctor would prescribe Estomil?

Estomil is approved to treat various conditions resulting from the stomach producing too much acid. Official indications include the healing of duodenal ulcers, treating damage to the food pipe (erosive esophagitis), and managing gastroesophageal reflux disease (GERD). It is also used for a specific condition called Zollinger-Ellison syndrome.

Q: Can I take Estomil if I have a history of heart problems?

Official warnings note that a rare, long-term side effect of Estomil is low blood magnesium (hypomagnesemia), which can sometimes affect heart rhythm. Furthermore, studies on infants have noted a potential for heart valve issues in those younger than one year of age. This information comes from official regulatory warnings.

Q: Are there any official restrictions on driving or operating machinery while on Estomil?

The official product information advises that some uncommon side effects, such as dizziness or fatigue, may occur during treatment with Estomil. If a person experiences these effects, their ability to drive or operate complex machinery may be impaired.

Q: What are the signs that Estomil might not be working for someone?

Official patient guidelines indicate signs that treatment may not be working as expected. These include if symptoms worsen or fail to improve after completing a recommended course of treatment, or if symptoms return quickly, such as sooner than four months after the end of treatment.

Q: Does Estomil interact with over-the-counter pain relievers like ibuprofen?

Official interaction studies indicate that Estomil generally does not have clinically significant interactions with over-the-counter pain relievers such as ibuprofen. In fact, Estomil is sometimes prescribed to reduce the risk of stomach ulcers in patients who require non-steroidal anti-inflammatory drugs (NSAIDs).

Q: What is the potential for interaction between Estomil and alcohol?

Regulatory guidance notes that excessive alcohol intake is not generally recommended during treatment. Patient information also states that avoidance of alcohol is described.

Q: What is the official definition of the condition Estomil is approved to treat?

Estomil is approved to treat conditions that are caused by too much stomach acid, such as duodenal ulcers and a condition called gastroesophageal reflux disease (GERD). GERD is officially described as a long-term condition where stomach acid frequently flows back into the tube connecting the mouth and stomach.

Q: Are there any mental or mood changes noted in research with Estomil?

Official safety information indicates that adverse events related to the central nervous system have been rarely reported in studies. However, mood changes such as anxiety or depression are not generally listed as common side effects associated with Estomil use.

Q: Is the effectiveness of Estomil affected by age?

Official clinical data states that a dose adjustment is generally not administered to the elderly. While some studies noted a slight increase in drug exposure in the elderly, its effectiveness is not typically considered to be significantly altered by age. However, some long-term risks, like bone fracture, are higher in this population.

Q: Is Estomil the same as [name of a popular, similar drug]?

Estomil contains the active ingredient Lansoprazole and belongs to the class of drugs called Proton Pump Inhibitors (PPIs). This class of medicine works by blocking a specific enzyme in the stomach to reduce acid production. Official sources state that all drugs in the PPI class share a similar mechanism of action to suppress stomach acid.

Q: Do studies support the use of Estomil for long-term treatment?

Official clinical studies support the use of Estomil for the long-term maintenance of healed conditions, such as ulcers. However, controlled studies often have a duration of 12 months or less. Official guidance states that regular review is necessary for treatment lasting longer than one year.

Q: Why do some people experience initial headaches when taking Estomil?

According to regulatory safety information, headache is listed as a common adverse effect associated with Estomil. Studies and official sources indicate that if a headache occurs, it is often experienced when first starting the medicine and may typically resolve within the first week of treatment.

Q: What does the term 'contraindications' mean for Estomil?

In official medical documents, a 'contraindication' describes a specific condition or circumstance where the use of a medicine, such as Estomil, is considered potentially harmful. Therefore, if a patient has a listed contraindication, the drug is generally not administered.

Q: Are there different strengths or forms of Estomil available?

Official product information confirms that the active ingredient Lansoprazole is available in different strengths, such as 15 mg and 30 mg. It is also available in various forms, including delayed-release capsules and orally disintegrating tablets.

Q: How is Estomil metabolized or removed from the body?

Estomil is absorbed quickly and then primarily broken down, or metabolized, in the liver by specific enzymes known as CYP2C19 and CYP3A4. After being metabolized, the remnants of the medicine are mostly eliminated from the body through the urine and feces.

Q: What kind of research has been done on Estomil in diverse populations?

Clinical data from official sources examines the use of Estomil in specific groups, including children, the elderly, and patients with certain medical conditions like liver impairment. Research also addresses how genetic variations, such as those in the CYP2C19 enzyme, can affect how the medicine is processed in different populations.

Q: How long after discontinuing Estomil do its effects leave the system?

The plasma half-life of the active drug in the blood is relatively short (about 1.5 hours). However, the acid-reducing effect lasts much longer because the medicine works by irreversibly blocking the acid pumps in the stomach. Official information indicates that the body must create new acid pumps to restore full acid secretion, a process that takes several days.

Q: What is the function of the inactive ingredients in Estomil?

Inactive ingredients in Estomil play important roles in the medicine's delivery. According to official documents, the key function is often to form the delayed-release or enteric coating that protects the acid-sensitive Lansoprazole from being destroyed by stomach acid before it can be absorbed in the intestine.

Q: Are there specific symptoms that warrant calling a doctor immediately while on Estomil?

Official safety warnings list several severe symptoms that are classified as urgent and necessitate immediate medical review. These include signs of a serious skin reaction, such as a severe, widespread rash, as well as symptoms like unexplained significant weight loss, severe difficulty or pain when swallowing, or chest pain spreading to the arms or shoulders.

Q: Do patients generally tolerate Estomil well?

Studies and regulatory data indicate that Estomil is generally tolerated by most patients. The majority of reported adverse reactions are common, such as headache and diarrhea, and are typically classified as mild to moderate in severity. Serious adverse effects are officially noted to occur rarely.

Q: What kind of studies led to Estomil's initial approval?

The initial regulatory approval of Estomil was based on data from various clinical trials. These included randomized controlled trials (RCTs) that compared the medicine to a placebo (a non-active treatment) or to other established therapies. These studies informed regulatory bodies on the agent's characteristics, including its effect on healing ulcers and relieving symptoms.

Q: Is it normal to feel a dry mouth or mild stomach upset with Estomil?

Official safety information indicates that dry mouth is a possible side effect of Estomil. Mild stomach upset is also a common occurrence, with common side effects listed as including diarrhea, abdominal pain, nausea, and constipation.

How should Estomil be stored and disposed of?

How to Store and Dispose of Estomil?

Storing Estomil (Lansoprazole) requires strict adherence to official regulatory conditions to maintain the stability of the medicine.

Storage Parameter Official Requirement
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F).
Protection Protect the medicine from moisture, and do not freeze the product.
Packaging Keep the container tightly closed and store the product in its original packaging.
Child Safety Keep this medicine out of the sight and reach of children.
Stability For products supplied in a bottle, discard unused medicine three months after the container is first opened.

Disposal must follow local regulatory requirements. Unused or expired Estomil should not be disposed of in household waste or wastewater. The preferred method is using an authorized drug take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Estomil found in:

A-Z Index: